Relationships Among Morphine Metabolism, Pain and Side Effects During Long-Term Treatment
Open Access
- 1 January 2003
- journal article
- review article
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 25 (1) , 74-91
- https://doi.org/10.1016/s0885-3924(02)00531-6
Abstract
No abstract availableKeywords
This publication has 116 references indexed in Scilit:
- Morphine-6-glucuronide, a potent mu agonistPublished by Elsevier ,2002
- Steady-State Kinetics and Dynamics of Morphine in Cancer Patients: Is Sedation Related to the Absorption Rate of Morphine?Journal of Pain and Symptom Management, 1999
- Analgesic responses to intrathecal morphine in relation to CSF concentrations of morphine-3,β-glucuronide and morphine-6,β-glucuronideLife Sciences, 1999
- Plasma morphine and glucuronide (M3G and M6G) concentrations in hospice inpatientsJournal of Pain and Symptom Management, 1997
- Morphine and morphine-6-glucuronide plasma concentrations and effect in cancer painJournal of Pain and Symptom Management, 1996
- Morphine-3-glucuronide: Silent regulator of morphine actionsLife Sciences, 1994
- Morphine and morphine metabolite kinetics in the rat brain as assessed by transcortical microdialysisLife Sciences, 1994
- The excitatory effects of morphine-3-glucuronide are attenuated by LY274614, a competitive NMDA receptor antagonist, and by midazolam, an agonist at the benzodiazepine site on the GABAA receptor complexLife Sciences, 1994
- Chronic nausea and morphine-6-glucuronideJournal of Pain and Symptom Management, 1991
- Morphine-3-glucuronide - a potent antagonist of morphine analgesiaLife Sciences, 1990